HB 2385 - Prohibits Manufacturers From Interfering in the Sale or Delivery of 340B Drugs and Provides Penalties - Oregon Key Vote

Timeline

Related Issues

Stage Details

Title: Prohibits Manufacturers From Interfering in the Sale or Delivery of 340B Drugs and Provides Penalties

See How Your Politicians Voted

Title: Prohibits Manufacturers From Interfering in the Sale or Delivery of 340B Drugs and Provides Penalties

Vote Smart's Synopsis:

Vote to concur with Senate amendments and pass a bill that prohibits manufacturers from interfering in the sale or delivery of 340B drugs in Oregon and provides penalties.

Highlights:

  • Prohibits manufacturers or third parties on behalf of a manufacturer from denying, restricting, prohibiting, or otherwise interfering with the acquisition, delivery, or dispensation of a 340B drug by a pharmacy that has contracted with a covered entity to receive and dispense such drugs (Sec. 1).

  • Prohibits manufacturers or third parties on behalf of a manufacturer from requiring a covered entity to submit a claim or utilization review data as a condition for the acquisition, delivery, or dispensation of a 340B drug by a pharmacy that is in contract with a covered entity (Sec. 1).

  • Authorizes the State Board of Pharmacy to impose a civil penalty on a manufacturer for each violation under Section 1 of this Act in an amount up to $5,000 per day (Sec. 2).

  • Specifies that civil penalties collected under this Section will be deposited into the State Board of Pharmacy Account (Sec. 2).

See How Your Politicians Voted

Title: Prohibits Manufacturers From Interfering in the Sale or Delivery of 340B Drugs and Provides Penalties

Vote Smart's Synopsis:

Vote to amend and pass a bill that prohibits manufacturers from interfering in the sale or delivery of 340B drugs in Oregon and provides penalties.

Highlights:

  • Prohibits manufacturers or third parties on behalf of a manufacturer from denying, restricting, prohibiting, or otherwise interfering with the acquisition, delivery, or dispensation of a 340B drug by a pharmacy that has contracted with a covered entity to receive and dispense such drugs (Sec. 1).

  • Prohibits manufacturers or third parties on behalf of a manufacturer from requiring a covered entity to submit a claim or utilization review data as a condition for the acquisition, delivery, or dispensation of a 340B drug by a pharmacy that is in contract with a covered entity (Sec. 1).

  • Authorizes the State Board of Pharmacy to impose a civil penalty on a manufacturer for each violation under Section 1 of this Act in an amount up to $5,000 per day (Sec. 2).

  • Specifies that civil penalties collected under this Section will be deposited into the State Board of Pharmacy Account (Sec. 2).

Title: Prohibits Manufacturers From Interfering in the Sale or Delivery of 340B Drugs and Provides Penalties

Title: Prohibits Manufacturers From Interfering in the Sale or Delivery of 340B Drugs and Provides Penalties

arrow_upward